Researchers conducted a randomized trial that compared the effects of 3 treatment regimens for the prevention of tuberculosis infection among individuals with HIV infection currently taking antiretroviral therapy.
Researchers investigated the prevalence, natural history, and clinical significance of pulmonary disease in outpatients with SARS-CoV-2.
Immunity against neuraminidase is important to consider in development of therapeutics and influenza vaccines with improved efficacy and protection.
Analysis of 10 years of data revealed that racial and ethnic minorities experienced more adverse outcomes from severe influenza.
Researchers conducted a systematic review and meta-analysis that compared outcomes of 4 antiviral agents for the treatment of patients with seasonal influenza.
No postacute histopathologic changes indicative of permanent pulmonary damage were observed among a small sample of COVID-19 survivors who have recovered and become asymptomatic.
Taking a drug meant for horses and cattle to prevent or treat COVID-19 is dangerous and could be fatal, the US Food and Drug Administration warns.
In this meta-analysis of studies on COVID-19 and SARS, researchers compared the association between all-cause mortality and treatment with glucocorticoids.
This study aims to assess anakinra’s safety and efficacy for treating severe COVID-19 vs the standard of care.
As HIV-exposed, uninfected infants have higher rates of morbidity and mortality than HIV-unexposed uninfected infants, a study was conducted to analyze whether particular infections or immune responses contribute to hospitalization.
